All News #Library
Biotech
Glenmark Starts Multi-Nation Phase 3 Trials for Lung Cancer Drug
05 Sep 2025 //
BUSINESS STD
Glenmark Launches Multi-Country Ph 3 Trial for Envafolimab
05 Sep 2025 //
EXPRESSPHARMA
Glenmark Pharmaceuticals launches TEVIMBRA in India
25 Jun 2025 //
INDPHARMAPOST
Glenmark Launches Tevimbra in India for Lung, Esophageal Cancer
24 Jun 2025 //
EXPRESSPHARMA
Glenmark Pharma Gains 4% On Positive Antibody Drug Trials
10 Dec 2024 //
BUSINESS STD
Ichnos Glenmark Presents Data on ISB 2001 in Multiple Myeloma
09 Dec 2024 //
GLOBENEWSWIRE
Ichnos-Glenmark Antibody Outperforms J&J`s Tecvayli In Mice Study
17 Sep 2024 //
FIERCE BIOTECH
Glenmark unit ties up with BeiGene to market cancer drugs in India
21 May 2024 //
MONEYCONTROL
Glenmark to launch biosimilar of anti-diabetic drug Liraglutide in India
03 Jan 2024 //
INDIAN PHARMA POST
Glenmark Pharma slashes price of breast cancer drug Trastuzumab
15 Jun 2023 //
ECONOMIC TIMES
Glenmark`s biotech company Ichnos Sciences lays off 50
28 Feb 2023 //
ENDPTS
India`s Eris Lifesciences to buy some dermatology brands from Glenmark Pharma
18 Jan 2023 //
REUTERS

Market Place
Sourcing Support